Sandrine Billet employs novel mouse models to test signaling mechanisms that contribute to cancer expansion and metastatic progression.
Supriya Borah studies the role of mitochondria in stromal epithelial communication and chemotherapy resistance.
Gabrielle Gonzales performs histology and cytology methods to support analysis of tumor progression and therapy resistance.
Carlos David Cruz Hernandez is examining the epigenetic changes induced by a high-fat diet and its influence on liver metastasis of solid tumors.
Hayato Muranaka is exploring mechanisms of liver metastasis. His research focuses on how dietary fat alters the signaling pathways in the liver niche and cancer cells to enable metastatic engraftment.
Krizia Rohena-Rivera studies the role of ketone metabolism in bladder and prostate cancer progression and development of resistance to chemotherapy and androgen-targeted therapy, respectively.
Bethany Smith examines the role of androgen signaling in the prostate cancer microenvironment that contributes to therapy resistance and changes in cancer metabolism.
Manish Thiruvalluvan investigates the role of glutamine in prostate cancer and the downstream signaling that involve the acquisition of resistance to irradiation.
Le Zhang studies the role of cholesterol and fatty acids on prostate cancer metabolic reprogramming, tumor progression and metastasis.